Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Fervent Pharma Synergies

Sector: Healthcare | Industry: Drugs & Pharma
R 15.50 0.00  | 0.00% -39.22% 43.22 46.50
BSE Price: Dec 06, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Dec 06, 2019 15.50 0.00 0.00% 15.50 15.50 1 15.50 - 15.50
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 790 P/B: 1.09 NSE Code:
52-Week Range: R 10.30 - 32.00 Dividend Yield: 0.00% BSE Code: 533896
TTM EPS: R 0.36 Book Value: R 14.29 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Fervent Pharma Synergies -39.10 1.64 -33.76 -39.22 -19.76 -21.63 -
S&P BSE Small Cap* -8.51 -0.49 7.68 -6.16 3.56 3.23 5.53
S&P BSE Healthcare* -3.24 2.16 4.31 -2.91 -4.93 -2.03 10.33
Company's return has been calculated on basis of BSE's price.
As on Dec 06, 2019
*As on Dec 05, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 202.62 65.55 44.68
Net Profit 48.55 -13.50 -1.50
EPS 48.55 -13.50 -5.03
Book Value 2.34 3.72 4.63
Average
Operating Margin 10.89 13.61 40.76
Net Margin 7.22 9.39 26.96
Return on Networth 2.92 3.67 4.43
Return on Investment 4.27 5.30 6.53
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -1.43 -23.56 -90.61
Operating Profit 13.07 -30.77 3,114.29
Net Profit 49.59 -18.58 475.51
EPS 49.51 -19.02 476.07
TTM
Revenue -0.64 347.32 -1.36
Operating Profit -5.94 199.81 -12.73
Net Profit -3.76 189.25 -12.73
EPS -3.86 188.58 -12.81
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Fervent Pharma Synergies 46.50 16.44 1.08 6.38 2.92 1.09 43.22
Astrazeneca Pharma India 6,631.63 818.54 74.85 8.97 20.03 20.12 88.60
Procter & Gamble Health 7,064.70 894.23 835.89 14.21 73.79 9.06 52.71
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jul 22, 2015 Vijay Pravinchandra Thakkar  Sell Market 129,040 67.10 86.59
Jul 17, 2015 Vijay Pravinchandra Thakkar  Sell Market 200,000 70.40 140.80
Jul 14, 2015 Vijay Pravinchandra Thakkar  Sell Market 215,000 71.50 153.73
Jul 08, 2015 Vijay Pravinchandra Thakkar  Sell Market 139,702 78.05 109.04
Jul 06, 2015 Vijay Pravinchandra Thakkar  Sell Market 599,335 78.30 469.28
News & Announcements
Contact Information

Company: Fervent Pharma Synergies Ltd.

Address: B / 7 - 8 , Satyam Shopping Centre, M G Road, Ghatkopar (E), Mumbai, Maharashtra - 400077 | Phone: 022-25017801/02/03 | Fax: 022-25017801/02/03

Email: [email protected]

Website: www.ferventsynergies.com

Registrar & Transfer Agent: Sharex Dynamic (India) Pvt Ltd

Address: C 101, 247 Park, L B S Marg, Vikhroli (West), Mumbai 400 083.Tel: 2851 5606/ 2851 5644 Fax: 2851 2885E-mail: [email protected], C 101, 247 Park, L B S Marg, Vikhroli (West) | Phone: 2851 5606/ 2851 5644 | Fax: 2851 2885

Essential checks
Altman Z-Score
40.78
Piotroski F-Score
7
Modified C-Score
3
5-Years Price to Earnings
43.22
5-Years Price to Book
1.09
Earnings Yield
EBIT / Enterprise value
4.72%
PEG
Price / Earnings to growth ratio
-5.35
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,652.10 -2.42%
Eris Lifesciences R476.35 +7.39%
FDC R206.25 +4.14%
Granules India R121.50 -4.44%
JB Chemicals & Pharma R403.25 +0.41%
Laurus Labs R340.20 -1.05%
Procter & Gamble Health R4,255.45 -1.09%
Strides Pharma Science R378.05 -0.49%
Sun Pharma Adv. Research R153.80 -1.51%
Suven Life Sciences R279.55 +2.46%
As on Dec 06, 15:59